Northern Trust’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Northern Trust’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-260,917	Closed	-$9.38M	–	4701
2022 Q4	$9.38M	Buy	260,917 +11,194	+4%	+$280K	﹤0.01%	2056
2022 Q3	$3.76M	Buy	249,723 +24,712	+11%	+$401K	﹤0.01%	2660
2022 Q2	$3.01M	Buy	225,011 +48,678	+28%	+$773K	﹤0.01%	2831
2022 Q1	$3.4M	Buy	176,333 +69,211	+65%	+$1.44M	﹤0.01%	2809
2021 Q4	$2.54M	Buy	107,122 +21,413	+25%	+$496K	﹤0.01%	3109
2021 Q3	$1.72M	Buy	+85,709	New	+$1.84M	﹤0.01%	3362

Northern Trust's IMGO Position: Q1 2023 in Review

Northern Trust sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 260,917 shares — an estimated $9.38M sold.

Northern Trust first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $9.38M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Northern Trust reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Northern Trust sold 260,917 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $9.38M.
Northern Trust first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Northern Trust's Imago BioSciences, Inc. Common stock position peaked at $9.38M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.